mPEG-DTA-1 / HO-PEG-DTA-5
LNP Excipient for Nucleic Acid Delivery
Commercial/PlatformPatented
Key Facts
Indication
LNP Excipient for Nucleic Acid Delivery
Phase
Commercial/Platform
Status
Patented
Company
About Sinopeg
A leading manufacturer of PEG derivatives and lipid excipients for advanced drug delivery systems, including mRNA vaccines and long-acting biologics.
View full company profile